Cargando…

Knowledge Mapping of Drug Repositioning’s Theme and Development

BACKGROUND: In recent years, the emergence of new diseases and resistance to known diseases have led to increasing demand for new drugs. By means of bibliometric analysis, this paper studied the relevant articles on drug repositioning in recent years and analyzed the current research foci and trends...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Xiaona, Liu, Jinlei, Zhang, Guangzhong, Feng, Xin, Dan, Wenchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122475/
https://www.ncbi.nlm.nih.gov/pubmed/37096060
http://dx.doi.org/10.2147/DDDT.S405906
_version_ 1785029498903724032
author Lang, Xiaona
Liu, Jinlei
Zhang, Guangzhong
Feng, Xin
Dan, Wenchao
author_facet Lang, Xiaona
Liu, Jinlei
Zhang, Guangzhong
Feng, Xin
Dan, Wenchao
author_sort Lang, Xiaona
collection PubMed
description BACKGROUND: In recent years, the emergence of new diseases and resistance to known diseases have led to increasing demand for new drugs. By means of bibliometric analysis, this paper studied the relevant articles on drug repositioning in recent years and analyzed the current research foci and trends. METHODOLOGY: The Web of Science database was searched to collect all relevant literature on drug repositioning from 2001 to 2022. These data were imported into CiteSpace and bibliometric online analysis platforms for bibliometric analysis. The processed data and visualized images predict the development trends in the research field. RESULTS: The quality and quantity of articles published after 2011 have improved significantly, with 45 of them cited more than 100 times. Articles posted by journals from different countries have high citation values. Authors from other institutions have also collaborated to analyze drug rediscovery. Keywords found in the literature include molecular docking (N=223), virtual screening (N=170), drug discovery (N=126), machine learning (N=125), and drug-target interaction (N=68); these words represent the core content of drug repositioning. CONCLUSION: The key focus of drug research and development is related to the discovery of new indications for drugs. Researchers are starting to retarget drugs after analyzing online databases and clinical trials. More and more drugs are being targeted at other diseases to treat more patients, based on saving money and time. It is worth noting that researchers need more financial and technical support to complete drug development.
format Online
Article
Text
id pubmed-10122475
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101224752023-04-23 Knowledge Mapping of Drug Repositioning’s Theme and Development Lang, Xiaona Liu, Jinlei Zhang, Guangzhong Feng, Xin Dan, Wenchao Drug Des Devel Ther Review BACKGROUND: In recent years, the emergence of new diseases and resistance to known diseases have led to increasing demand for new drugs. By means of bibliometric analysis, this paper studied the relevant articles on drug repositioning in recent years and analyzed the current research foci and trends. METHODOLOGY: The Web of Science database was searched to collect all relevant literature on drug repositioning from 2001 to 2022. These data were imported into CiteSpace and bibliometric online analysis platforms for bibliometric analysis. The processed data and visualized images predict the development trends in the research field. RESULTS: The quality and quantity of articles published after 2011 have improved significantly, with 45 of them cited more than 100 times. Articles posted by journals from different countries have high citation values. Authors from other institutions have also collaborated to analyze drug rediscovery. Keywords found in the literature include molecular docking (N=223), virtual screening (N=170), drug discovery (N=126), machine learning (N=125), and drug-target interaction (N=68); these words represent the core content of drug repositioning. CONCLUSION: The key focus of drug research and development is related to the discovery of new indications for drugs. Researchers are starting to retarget drugs after analyzing online databases and clinical trials. More and more drugs are being targeted at other diseases to treat more patients, based on saving money and time. It is worth noting that researchers need more financial and technical support to complete drug development. Dove 2023-04-18 /pmc/articles/PMC10122475/ /pubmed/37096060 http://dx.doi.org/10.2147/DDDT.S405906 Text en © 2023 Lang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Lang, Xiaona
Liu, Jinlei
Zhang, Guangzhong
Feng, Xin
Dan, Wenchao
Knowledge Mapping of Drug Repositioning’s Theme and Development
title Knowledge Mapping of Drug Repositioning’s Theme and Development
title_full Knowledge Mapping of Drug Repositioning’s Theme and Development
title_fullStr Knowledge Mapping of Drug Repositioning’s Theme and Development
title_full_unstemmed Knowledge Mapping of Drug Repositioning’s Theme and Development
title_short Knowledge Mapping of Drug Repositioning’s Theme and Development
title_sort knowledge mapping of drug repositioning’s theme and development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122475/
https://www.ncbi.nlm.nih.gov/pubmed/37096060
http://dx.doi.org/10.2147/DDDT.S405906
work_keys_str_mv AT langxiaona knowledgemappingofdrugrepositioningsthemeanddevelopment
AT liujinlei knowledgemappingofdrugrepositioningsthemeanddevelopment
AT zhangguangzhong knowledgemappingofdrugrepositioningsthemeanddevelopment
AT fengxin knowledgemappingofdrugrepositioningsthemeanddevelopment
AT danwenchao knowledgemappingofdrugrepositioningsthemeanddevelopment